EyePoint Pharmaceuticals, Inc. 8-K

Accession 0001564590-22-004855

Filing information

CIK: 0001314102
Report date: 2022-02-14
Filing date: 2022-02-14
Form: 8-K
Primary document: eypt-8k_20220214.htm

Open primary document

View the filing document on sec.gov.

Open EDGAR directory

Inspect all files for this filing.

Complete submission file

Open the raw SEC submission text.